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Abstract Protein tyrosine phosphorylation, modulated by the 
rate of both protein tyrosine kinase and protein tyrosine 
phosphatase activities, is critical for cellular signal transduction 
cascades. We report that endothelin-l stimulation of rabbit 
platelets resulted in a dose- and time-dependent tyrosine 
phosphorylation of four groups of proteins in the molecular 
mass ranges of 50,60,70-100 and 100-200 kDa and that one of 
these corresponds to focal adhesion kinase. This effect is also 
related to the approximately 60% decrease in protein tyrosine 
phosphatase activity. Moreover, this inhibited activity was less 
sensitive to orthovanadate. In the presence of forskolin that 
increases the cAMP level a dose-dependent inhibition of the 
endothelin-stimulated tyrosine phosphorylation of different 
protein substrates and a correlation with an increase in the 
protein tyrosine phosphatase activity (1l.6-fold compared to 
control) have been found. Further studies by immunoblotting of 
immunoprecipitated soluble fraction with anti-protein tyrosine 
phosphatase-l C from endothelin-stimulated platelets have dem-
onstrated that the tyrosine phosphorylation of platelet protein 
tyrosine phosphatase-l C is correlated with the decrease in its 
phosphatase activity. As a consequence, modulation and regula-
tion by endothelin-l in rabbit platelets can be proposed through a 
cAMP-dependent pathway and a tyrosine phosphorylation 
process that may affect some relevant proteins such as focal 
adhesion kinase. 
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1. Introduction 
The importance of protein tyrosine phosphorylation in the 
control of cellular processes such as growth, differentiation or 
transformation, and cytoskeletal integrity, has been well es-
tablished [1,2]. The overall cellular phospho tyrosine levels are 
controlled by the dynamic balance of the action of both pro-
tein tyrosine kinases that catalyze phosphorylation and pro-
tein tyrosine phosphatases (PTP) which are responsible for 
dephosphorylation of tyrosyl residues [3,4]. The coordination 
of cellular phosphorylation/dephosphorylation events, i.e. the 
selection of the proper substrates and the coordination of the 
moments for protein tyrosine kinases and PTP action, is 
mainly conditioned by the restricted subcellular distribution 
of these two activities through their subcellular compartmen-
talization [5] or their activators [6]. 
Protein tyrosine phosphatases have no structural homology 
with the Serrrhr-protein phosphatases and are divided into 
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two families that include transmembrane receptor-like en-
zymes and intracellular proteins (non-receptor-like enzymes) 
[7,8]. These proteins that hydrolyze phosphotyrosyl groups 
have been involved in several cellular functions like tumor 
suppression [9], cytoskeletal reorganization [10], development 
and differentiation [11,12], mitotic induction [13] or growth 
factor [14] signaling pathways. 
Previous studies have described the presence of PTPs in 
platelets. Thus, the membrane PTP of 53 kDa [IS] or PTP-
I B, a calpain substrate in thrombin-stimulated platelets, has 
been described [16]. In addition, two other PTPs were studied 
in platelets, the 105 kDa PTPHI [17] and SH-PTPI or PTP-
I C which is predominantly expressed in hematopoietic cells 
and contains two Src homology-2 domains (SH2) [18]. Par-
ticularly interesting for platelet function is the PTP-IC, a crit-
ical enzyme associated with the cytoskeleton of thrombin-
stimulated platelets [19]. 
The effect of endothelin-l on the PTP activity has been 
studied in this paper, based on the integration of PTPs and 
protein tyrosine kinases activities in the control of cell func-
tion by their coordinated effect at the time of controlling 
tyrosine phosphorylation-dependent signaling pathways. 
Endothelin-l is produced by endothelial cells [20] and has 
some effect in many physiological systems through signal 
transduction pathways such as phospholipase C activation, 
cytosolic-free Ca2+ levels elevation and protein kinase C acti-
vation [21]. 
As we have previously demonstrated that endothelin-I has 
a direct effect on the stimulation of several tyrosine phos-
phorylated proteins in rabbit platelets and that there is a 
novel pathway for platelet signal transduction in which the 
cAMP level could be involved in the endothelin effect on 
tyrosine phosphorylation [22]. In the present study we have 
evaluated the effect of endothelin-l on PTP activity in order 
to establish the possible coordinated action of protein tyrosine 
phosphatases, in particular PTP-IC and kinases in rabbit 
platelets. The relationship between this effect and the modula-
tion, by tyrosine phosphorylation, of some relevant proteins 
such as the focal adhesion kinase protein (F AK), has been 
also studied. 
2. Materials and methods 
2.1. Materials 
Endothelin-I, forskolin, sodium orthovanadate and O-phosphoty-
rosine were purchased from Sigma. Nitrocellulose membranes were 
obtained from Renner GmbH. Monoclonal anti-phosphotyrosine 
(PY20), anti-PTP-IC and anti-FAK antibodies were from Affiniti Re-
search Products Ltd. Goat anti-(mouse IgG)-horseradish-peroxidase 
conjugate was purchased from Nordic Immunology. Enhanced chem-
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iluminescence (ECL) system was acquired from Amersham Interna-
tional. Protein A-Sepharose was from Pharmacia Biotech Inc. 
2.2. Isolation of rabbit platelets 
Rabbit platelets were prepared as described earlier [23] from blood 
collected in 3.2% trisodium citrate. Platelets were suspended in 
HEPES-Tyrode's solution (10 mM N-2-hydroxyethylpi-perazin-N'-
2-ethanesulfonic acid, 145 mM NaCI, 5 mM KCI, I mM MgCh, 
0.5 mM Na2HP04, 5 mM glucose and 12 mM NaHC03, pH 7.4). 
The platelet number was estimated through the protein concentration 
determined by the Bradford method [24] using Bio-Rad protein assay 
reagent and bovine serum albumin as standard. 
2.3. Stimulation of platelets 
One hundred thirty micrograms of platelet protein (::::: 6.9 X 107 pla-
telets) suspended in Tyrode's buffer, pH 7.4, was stimulated by incu-
bation with 2 ~M endothelin-l for 2 min in the absence or presence of 
the appropriate concentrations of forskolin. Platelets were preincu-
bated for 3 min in the presence of forskolin, prior to stimulation 
with endothelin-1. At the end of each stimulation period, incubations 
were stopped at 4°C and centrifuged at 15000Xg for 15 min. The 
resulting platelets pellet was washed with Tyrode's buffer, pH 7.4, and 
resuspended in buffer containing 10 mM PIPES, pH 6.5, 0.2 mM 
EDTA, 145 mM NaCI, 5 mM KCI, 5.5 mM dextrose, 4.8 ~g/ml 
leupeptin and I ~g/ml aprotinin. The suspension was frozen 3 times 
in liquid nitrogen. Protein concentration of this platelet suspension 
ranged from I to 2 mg/ml. This platelet preparation was processed in 
PAGE-SDS or subjected to PTP activity quantification. 
2.4. Protein tyrosine phosphatase activity 
PTP activity was assayed at 37°C by slight modification of the 
methods of Mustelin [25] and Smilowitz [26] in a reaction mixture 
(final volume: 250 ~I) containing 100 mM sodium acetate buffer, 
pH 6.0, 10-20 ~g freshly thawed platelet protein, 10 mM O-phospho-
tyrosine as substrate, and 0.2% Triton X-IOO. The reaction was 
started by adding the substrate dissolved in the same sodium acetate 
buffer, and stopped by adding an equal volume of 1 M NaOH. The 
tyrosine produced was measured spectrophotometrically [27] by using 
~93.5 = 2330 M- 1 cm-1 , all in alkaline solution. The endogenous ty-
rosine was estimated in the absence of substrate. 
2.5. Immunoprecipitation and immunoblotting 
For immunoprecipitation experiments platelets were prepared and 
stimulated as described above with 2 ~M endothelin-I for 30 s, and 
the reaction stopped by platelets lysis in 50 mM HEPES, pH 7.2 
buffer, supplemented with 10 mM sodium pyrophosphate, 10 mM 
sodium orthovanadate, 2 mM EDTA, 10 mM sodium molybdate, 2 
~g/ml aprotinin, 40 ~g/ml leupeptin and I mM phenylmethylsulfonyl 
fluoride. Immunoprecipitations were performed by incubation of the 
samples (::::: 100 ~g of protein), redissolved in one volume of solubili-
zation buffer (40 mM Tris-HCI, pH 7.5, 2% Triton X-lOO, 1.8% NaCI, 
4 ~g/ml aprotinin and 40 ~g/ml leupeptin), with 10 ~g of mouse 
primary monoclonal antibody or non-immune control serum, at 
37°C for I hand 3 h at 4°C. Immune complexes were collected 
with Protein A-Sepharose, diluted I: I in PBS (10 mM sodium phos-
phate, pH 7.5, 140 mM NaC!) at 4°C for 2 h. The beads were washed 
once with cold buffers (10 mM Tris-HCI, pH 8.0, 0.3 M NaC!, 2% 
Triton X-IOO; 10 mM Tris-HCI, pH 8.0, 0.5 M NaC!, 0.1% Triton X-
100 and 10 mM Tris-HCI, pH 8.0, 0.05% Triton X-IOO), dissolved by 
boiling in SDS Laemmli sample buffer [28], and subjected to standard 
SDS-PAGE on 12% polyacrylamide gels. Proteins were then trans-
ferred to nitrocellulose paper by a wet blotting method (overnight 
at 200 rnA). The non-specific binding was blocked with 1% BSA in 
10 mM Tris-HCI, pH 7.5, 100 mM NaCI and 0.1% Tween 20, and the 
proteins were probed with anti-phosphotyrosine, anti-PTP-IC and 
anti-FAK monoclonal antibodies and detected using the ECL system 
with horseradish peroxidase-conjugated secondary antibodies accord-
ing to the manufacturer's protocol. The immunoprecipitated PTP ac-
tivity was measured, as described above, in the immune complexes 
redissolved in 20 ~I of sodium acetate buffer. 
3. Results and discussion 
As protein tyrosine kinases have been related to intracellu-
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lar signaling enzymes and to the activation of some mecha-
nisms of signaling cascades, our results attempt to further 
define the possible effect of endothelin-I on the early events 
of the signal transduction pathways in rabbit platelets, such as 
the phosphorylation of tyrosine residues. Using monoclonal 
anti-phospho tyrosine antibody, the effect of endothelin-I on 
the phosphorylation of protein tyrosine residues was studied 
on isolated rabbit platelets. Treatment of the platelets with 
2 11M endothelin-I for I min caused a rapid tyrosine phos-
phorylation affecting those proteins in the molecular mass 
range of 50, 60, 70-100 and 100-200 kDa (Fig. IA). Tyrosine 
phosphorylation in stimulated-platelets was at its highest level 
in the 60 kDa and 100-200 kDa proteins whereas in the 50 
kDa and 70-100 kDa proteins the effect was moderate (Fig. 
IB). By in vitro determination of total PTP activity in the 
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Fig. 1. Endothelin-l induction of tyrosine phosphorylation and ef-
fect on protein tyrosine phosphatase. Platelets were stimulated with 
endothelin-I, as described under Section 2. A: Western blot analysis 
of rabbit platelet proteins on 12% SDS-PAGE, immunoblotted with 
anti-phosphotyrosine antibody (PY20) (lanes 1 and 2) and with 
anti-FAK antibody (lanes 3 and 4). Arrow indicates FAK protein, 
lanes 2 and 4 endothelin-stimulated platelets, and lanes I and 3 rest-
ing platelets. B: Tyrosine phosphorylation level in the different mo-
lecular mass ranges of proteins in stimulated platelets (II1II) compared 
to resting platelets (control) (D). C: Effect of endothelin-I on total 
PTP activity (II) (0.09 U/mg protein) with respect to resting platelets 
(D) (0.22 U/mg protein). PTP activity was measured as described 
under Section 2 using 20 ~g platelet proteins at 37°C for 25 min. 
All results represent the mean ± SE of four separate experiments. 
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Fig. 2. Effect of forskolin on endothelin induction of tyrosine phos-
phorylation and on PTP activity. The stimulation of platelets with 
endothelin-I was performed in the absence (lane 1) or presence 
(lane 2) of 10 JlM forskolin, as described under Section 2. A: Tyro-
sine phosphorylated platelet proteins were analyzed on 12% SDS-
PAGE and the Western blotting was performed with PY20 anti-
body. B: Tyrosine phosphorylation level in the different molecular 
mass ranges of proteins in endothelin-stimulated platelets in the 
presence (dotted (right) columns) and absence of forskolin (shaded 
(left) columns). C: PTP activity of endothelin-stimulated platelets in 
the presence (dotted (right) column) (2.05 U/mg protein) and ab-
sence (shaded (left) column) (0.l8 U/mg protein) of forskolin. The 
enzymatic activity was measured as described under Section 2, using 
20 Jlg of platelet proteins at 37°C for 25 min. Results are represent-
ative as mean ± SE of four separate experiments. 
same samples (Fig. IC), the increase in tyrosine phosphoryla-
tion induced by endothelin-l was correlated with a significant 
inhibition of this activity (60%). The different level of tyrosine 
phosphorylation found here may be explained by a possible 
endothelin-induced regulatory effect of protein phosphatases 
that results in a different phosphorylation/dephosphorylation 
rate due to the coordinated action of protein tyrosine kinases 
and phosphatases. Taking into account that activation of pla-
telets by several agonists results in tyrosine phosphorylation 
for several cellular proteins including the F AK [29], we inves-
tigated whether the group of proteins in the molecular mass 
range of 100-200 kDa includes F AK protein. Results shown 
in Fig. lA demonstrate that tyrosine phosphorylation of this 
protein is linked to endothelin-l effect in rabbit platelets. 
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As previously proposed [22], endothelin-I-stimulated tyro-
sine phosphorylation in rabbit platelets can be significantly 
inhibited by agents that raise cAMP levels and, sensibly less 
by agents that raise cGMP levels, so the involvement of cyclic 
nucleotides on platelet tyrosine phosphorylation/dephospho-
rylation rate dis balance could be considered. This possible 
effect of cyclic nucleotides on this tyrosine phosphorylation 
stimulation and· on PTP activity inhibition by endothelin 
was studied by performing endothelin stimulation in the pres-
enCe of forskolin which increases the cAMP level. At a con-
centration of 10 11M, forskolin produces a marked inhibition 
of tyrosine phosphorylation induced by endothelin-l as shown 
on the Western blot analysis (Fig. 2A). An inhibitory effect 
was observed for 60 kDa and 100-200 kDa proteins (58% and 
47%, respectively) (Fig. 2B) and a slight one for 50 kDa and 
70-100 kDa (36% and 10%, respectively). Moreover, the spe-
cific activity of the PTP in whole rabbit platelets treated with 
endothelin-l in the presence of forskolin was 11.6-fold higher 
than in untreated platelets (Fig. 2C). In this sense, our results 
show that the decrease in protein tyrosine phosphorylation in 
endothelin-l-stimulated-platelets in the presence of forskolin 
is correlated to the dramatic increase in the PTP activity with 
this agent. In this regard, changes in cyclic nucleotide levels 
could affect the coordinated action of protein kinase and 
phosphatase activities in the signal transduction cascade. In 
fact, Cirri et al. [27] described that increase of intracellular 
concentration of cyclic nucleotides could stimulate some tyro-
sine phosphatase isoenzyme activities in vivo. Moreover, it 
has been recently described that modulation of cGMP metab-
olism is a mechanism through which the tyrosine kinase path-
way can interact with other signal transduction pathways [30]. 
Thus We can consider the possibility of an activation or in-
activation of more than one cyclic monophosphate nucleotide-
dependent protein tyrosine phosphatase following endothelin-
I stimulation as a function of the different responses to tyro-
sine phosphorylation inhibition of platelet proteins in the 
presence of agents which modify the levels of these nucleo-
tides. 
Considering the possibility of a modulator effect of en-
dothelin-l on platelet PTP activity, We have studied the effect 
of this neuropeptide on the PTP-l C that could participate, 
through its SH2 domains, in signal transduction pathways. 
Fig. 3A shows the SDS-PAGE analysis of proteins from 
platelet lysates and from immunoprecipitates with anti-PTP-
IC from endothelin-stimulated and resting platelets, subjected 
to immunoblotting with antibodies to phospho tyrosine 
(PY20) and to PTP-lC (a-PTP-IC). PTP-IC from platelet 
lysates and immunoprecipitates, that undergoes a tyrosine 
phosphorylation process, was subjected to PTP activity assay 
from endothelin-stimulated and resting platelets (Fig. 3B). 
These results show a relationship between the increase in the 
phosphorylation state of PTP-l C and the decrease in phos-
phatase activity. 
PTP-l C is known to be phosphorylated at tyrosine and 
serine residues [31,32]. It has been suggested that phosphoryl-
ation of PTP-lC could play an important role in the regula-
tion of this enzyme [31]. The results shown in the present 
paper are in agreement with those obtained by Garton and 
Tonks [33] in which phosphorylation of PTP-PEST (cytosolic 
PTP) led to a decrease in the phosphatase activity. In con-
trast, it has been described more recently that tyrosine phos-
phorylation of PTP-ID is correlated with an enhancement of 
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Fig. 3. Analysis of immunoprecipitated PTP-IC from endothelin-
stimulated platelets. Platelets were stimulated with endothelin-I for 
30 s as described under Section 2. Immunoprecipitations were per-
formed with anti-PTP-IC (aPTP-IC) and non-immune serum using 
Protein A-Sepharose. A. Immunoblotting of proteins from platelet 
Iysates and from immunoprecipitates probed with PY20 and aPTP-
IC antibodies. Lanes 1, 3, 5 and 8 unstimulated platelets; lanes 2, 
4, 6 and 9 endothelin-stimulated platelets. Lanes 7 and 10 corre-
spond to immunoprecipitations with control non-immune serum. 
Analysis of quantity and coincidence of PTP-IC (lanes 3, 4 and 8 
to 10) was performed by autoradiography of the same immunoblot 
used for PY20 after stripping and repro bing protocols with aPTP-
I C. The data shown belong to a single immunoblot representative 
of three separate experiments of immunoprecipitation. B: Determi-
nation of immunoprecipitated PTP-IC activity from resting (D) 
(0.2 Vlmg protein) and endothelin-stimulated platelets (III) (0.08 VI 
mg protein). The conditions and the assay method were as described 
under Section 2 and the activity was measured at 37°C for 25 min. 
Data represent mean ± SE from three separate experiments. (_) Vn-
detectable PTP activity in control non-immune serum. 
its catalytic activity [34]. This discrepancy can be based on the 
fact that, despite their close structural similarity, the two PTPs 
have distinct regulatory functions that may be related to their 
different activity on autophosphorylated receptors or to their 
ability to form complexes with receptor tyrosine kinases [34]. 
In any case, the stimulation or inactivation of tyrosine 
phosphatase activity by a phosphorylation process is one of 
the signal transduction pathways promoted by G-protein-
coupled receptors [35]. This could be correlated to the fact 
that endothelin receptors belong to this G-protein-coupled 
class [36] and, in consequence, an interconection between en-
dothelin-l effect on tyrosine phosphorylation and regulation 
of PTP activities can be proposed. Moreover, the effect of 
endothelin-l on tyrosine phosphorylation of F AK can be con-
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sidered an integrin-mediated event in rabbit platelets, as it has 
been previously described for other agonists [29]. 
Another feasible possibility is that the endothelin-l effect on 
tyrosine phosphorylation and on PTP activity in rabbit plate-
lets could be related with the general idea of a regulation of 
signal transduction cascades through protein-protein interac-
tions [37] activated by protein tyrosine kinases. In this sense, 
PTPs contain specific domains (Src homology 2 and 3 or SH2 
and SH3) [38] which could be involved in the interactions 
between cytoplasmic signaling molecules and specific phos-
photyrosyl residues on signaling molecules which could pro-
vide signal specificity, amplification processes or feed-back 
mechanisms [39]. PTP-l C particularly contains SH2 domains 
that allow a possible and direct linkage of this PTP to growth 
factor receptors, to other signaling proteins or to certain 
structural cell components, that could end up in the regulation 
of signal transduction through phosphorylation and dephos-
phorylation of tyrosine residues [40]. It is believed that intra-
cellular localization is a factor that could control the mecha-
nisms of action of the enzyme. In this regard, it is noticeable 
to point out that thrombin translocates PTP-l C in platelets 
[19]. In addition phorbol esters induce translocation and 
phosphorylation of PTP-l C in HL-60 cells [31]. Thus, we 
can speculate that endothelin-l could induce intracellular 
translocation of PTP-l C in platelets. 
Since platelet PTP is extremely sensitive to inhibition by 
sodium orthovanadate [26], this effect on endothelin-stimu-
lated and resting platelets was studied here. The in vitro re-
sults of PTP activity in the presence of different concentra-
tions of orthovanadate with respect to control in the absence 
of this inhibitor, are shown in Fig. 4. In the presence of 
5 X 10-4 M sodium orthovanadate, PTP activity from en-
dothelin-stimulated platelets was inhibited approximately 
43%, whereas PTP activity from resting platelets was more 
sensitive to this concentration of inhibitor (70%), with an 
IC50 of 50 JlM and 1 JlM, respectively. Thus, our data of a 
lower catalytic activity of the immunoprecipitated PTP com-
pared to total PTP activity (l50-fold, results in mU/mg pro-
tein not shown) and a lower sensitivity of PTP for orthovan-
adate in endothelin-l-stimulated platelets with respect to 
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Fig. 4. Dose-response to sodium orthovanadate, a specific inhibitor 
of PTP activity. PTP activity was measured as described under Sec-
tion 2 using 20 ~g freshly thawed platelet proteins at 37°C for 25 
min, in the absence and presence of this inhibitor at the different 
concentrations indicated, in endothelin-stimulated platelets (0) or in 
resting platelets (e). Results represent the mean ± SE of three sepa-
rate experiments. 
284 
control make us think of a possible inaccessibility of a con-
served cysteine residue that is essential for the PTP activity 
[41], or of an inhibitory site that implies different sensitivity to 
vanadate in the same way as it occurs in other cell systems 
[25] with a different particulate state of PTPs. 
In any case, the possible covalent states of platelet PTPs 
and their different sensitivity to inhibitors suggest that plate-
lets may contain multiple forms of these proteins, and that the 
presence of an agonist may modify these aspects. Thus, en-
dothelin-l could affect the possible coordinated action of pro-
tein tyrosine phosphatases and kinases in rabbit platelets and 
modulate, by tyrosine phosphorylation stimulation, some rel-
evant proteins, like focal adhesion kinase through integrin-
mediated events and a cAMP dependent pathway. 
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